A promising drug still needs a working diary, the right dose and a patient who knows what happens next. YPrime builds the software for those easily overlooked details.

She began in sales, learned finance, and built a career translating complicated technology into a business case. At Suvoda, Elena Filimonova now applies that discipline to the quiet machinery of clinical trials.
Suvoda built its reputation on the least glamorous, most unforgiving seconds in drug development: assigning the right patient to the right arm and putting the right medicine in the right place. Now, after merging with Greenphire, it wants to turn eight disconnected trial chores into one calm operating system.

He began as a self-described paper pusher, questioned the machinery from every seat he occupied, and built a career around making clinical research easier to enter and harder to abandon.